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Background: Rates of PTSD in active-duty military are high relative to the general population. Although effica
cious treatments exist, they are underutilized. Many service members with PTSD do not present for treatment
and, of those who do, many do not receive sufficient doses of the interventions to receive full benefits. Moti
vational Enhancement Therapy (MET) “check-ups”, are brief interventions designed to elicit treatment
engagement for those who are not treatment-seeking.
Methods: StressCheck is an MET for nontreatment seeking Army and Air Force personnel. StressCheck aims to
improve PTSD and increase treatment engagement, especially around evidence-based interventions, as well as to
decrease stigma about seeking mental health services and improve knowledge about treatment options. This
paper describes the intervention components and process of treatment development. The paper also describes
next steps in testing the effectiveness of the intervention.
Conclusion: PTSD is associated with deleterious health, occupational, and psychological effects. If effective, this
innovative intervention will bridge the gap between those who are not treatment seeking and existing services,
thereby enhancing reach and impact of existing services.
ClinicalTrials.gov identifier: NCT03423394

1. Introduction
Current and former military service members are at high risk for
posttraumatic stress disorder (PTSD) [1,2]. Studies have found postdeployment rates of PTSD ranging from 5 to 20% [3,4]. However,
PTSD is relatively responsive to treatment. Across all PTSD psycho
therapies 56% of those who entered treatment and 67% of completers no

longer met criteria for PTSD posttreatment [5]. Among military samples
with PTSD, the majority who received evidence-based trauma-focused
psychotherapy (60–72%) did retain their diagnosis; however, 49–70%
experienced clinically meaningful gains, representing notable
improvement in quality of life [6].
Despite availability of evidence-based therapies targeting PTSD,
service members often do not access treatment. Nearly 70% of adults
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with PTSD [7] and 63% of soldiers with mental health symptoms [8] did
not seek help within the past year. Among service members with PTSD,
less than half ask for help, and of those referred to specialty care, less
than half complete the referral [3,9].
Motivational interviewing (MI) may be one way to strengthen
treatment seeking and engagement. MI is a person-centered, directive
approach aimed at helping individuals resolve ambivalence for behavior
change. MI emphasizes a nonjudgmental counseling style that seeks to
understand client perspectives and reasons for change. A widely applied,
well-researched approach [10], MI has been evaluated as a prelude to
treatment [11], an adjunct to existing treatment such as cognitive
behavioral therapy [12], stand-alone treatment (Project MATCH) [13],
and as an aftercare or maintenance intervention [14,15].
Research on application of MI to PTSD treatment is still relatively
sparse. Among non-treatment-seeking Veterans with mental health
concerns—58% of whom had PTSD, receiving four sessions of
telephone-delivered MI increased treatment seeking and engagement
relative to usual care [16]. Adding a four-session group MI-based
intervention to a year-long group outpatient PTSD treatment increased
attendance and treatment retention compared to an education control
among veterans [17]. Thus, limited research on MI to enhance PTSD
treatment shows promise but has not focused on connecting nontreatment seeking service members to care.
MI has been adapted to motivate change among individuals who are
not treatment seeking—known as the Check-Up Model [18]. The CheckUp central premise is people experiencing difficulties but not engaged in
treatment, do so because of ambivalence about treatment. Check-Up
model interventions directly target individuals who are lower in readi
ness to change but also do attract, and include, a portion of individuals
who are already motivated to change a behavior. The Check-Up includes
an advertisement campaign to target individuals struggling with a
problem behavior but not accessing care. The Check-Up model combines
marketing with Motivational Enhancement Therapy (MET), an adapta
tion of MI, which includes individualized feedback based on standard
ized assessments and delivered in an MI style. The Check-Up model has
been successfully applied to a variety of behaviors [18,19] including
substance use among active-duty soldiers [20].
To fill these gaps, we developed a Check-Up MET intervention for
PTSD (“StressCheck”). This paper describes the development of the
intervention, components including the advertising and marketing
campaign materials, and principles used to develop StressCheck. The
randomized clinical trial protocol to test the intervention is also
described.

2.3. Phase 1: intervention development
2.3.1. Initial planning – delivery, structure, and content
Given high rates of treatment dropout and the role of avoidance in
maintaining PTSD, we created a 1- to 3-session telephone-delivered
intervention. Three sessions were selected to provide supports and sus
tain change in the face of ambivalence about treatment. StressCheck was
framed as a chance to “check-in” rather than psychotherapy. Phonebased MI interventions have shown efficacy with military populations
[16,20], and this mode of delivery maximizes dissemination potential
and increases likelihood of engaging service members who are reluctant
to seek counseling due to stigma, privacy worries, and logistical barriers
[21].
The first component of a Check-Up intervention is a marketing
campaign that attracts the target population and encourages engage
ment with the intervention. Marketing materials were developed uti
lizing McGuire’s [22] communication and persuasion matrix, which
focuses on five communication components: audience, content, delivery
modality, message source, and desired action. Thus, our marketing
materials focused on military personnel’s potential concerns regarding
PTSD symptoms, help-seeking, and messages that might prompt a
response. Intended marketing messages also focused on symptoms
rather than diagnostic labels, as this may be less stigmatizing and more
engaging for non-treatment seekers or those higher in ambivalence to
change. Lastly, we designed marketing materials to reach different types
of personnel. Drafts of nine advertisements were created based on the
research team’s prior MET “check-up” studies [23,24].
The second component is a Personalized Feedback Report (PFR) to
guide conversations between counselor and participant to address
ambivalence about seeking treatment while growing and sustaining
change talk. The preliminary intervention content, including the PFR
and accompanying treatment manual were developed by authors (DK,
TW, DW) to target mechanisms theorized to be motivators of, or de
terrents to, change. We included opportunities for participants to iden
tify discrepancies between their goals and values, and current behavior.
Lastly, we addressed stigma around treatment seeking, perceived prac
tical barriers to care, and provided information about treatment options
and effectiveness.
2.3.2. Focus group evaluation of draft intervention
Next, we convened focus groups with each of three stakeholder
groups to gather feedback about the initial draft of recruitment and
intervention materials. Stakeholder groups were: (1) active-duty
personnel who had previously engaged in pharmacotherapy or any
form of psychotherapy for the treatment of PTSD, (2) active-duty
personnel with probable PTSD who had not received treatment, and
(3) military service providers involved in PTSD treatment. Participants
were recruited through printed advertisements posted at various loca
tions throughout Joint Base Lewis-McChord (JBLM), such as gyms,
recreation centers, libraries, and cafeterias.
Prospective participants were invited to complete a brief screening,
delivered online or by phone. For service members, screening assessed
demographics, mental health treatment history, and probable PTSD via
the PTSD Checklist (PCL) [25]. A cut-score of 25 indicated probable
PTSD. Service providers were asked about their role in treatment pro
vision to ensure relevant experience. In total, 76 service members and
providers completed screening, and the 42 who met criteria for one of
the three groups were invited to participate. Final samples were deter
mined by participants’ availability (treated, n = 8; non-treated, n = 6;
provider, n = 8).
Focus groups were held at JBLM. After providing written informed
consent, participants were asked to view draft recruitment posters, rate
them as favorable or unfavorable, and participate in a discussion about
reactions to those ads and possibilities for additional ads. The groups
also reviewed each section of the draft PFR, discussing reactions to the
content, presentation, and order of PFR sections. Each group was audio-

2. Material and methods
2.1. Research design
The purpose of this two-phase study is to design and evaluate the
StressCheck intervention. In Phase 1, we developed the novel MET
intervention in collaboration with focus groups. In Phase 2, we will
evaluate its efficacy in a randomized controlled trial. Both phases have
been approved by the University of Washington Institutional Review
Board and the DoD Human Research Protections Office, neither of which
recommended the use of a Data and Safety Monitoring Board. Subjects in
both phases will provide informed consent prior to their participation.
2.2. Target population
StressCheck is designed for active-duty service members with PTSD
not currently engaged in evidence-based PTSD treatment. The goal is to
increase treatment engagement, move participants toward treatment,
and toward more effective treatment.
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recorded and two note-takers recorded participants’ feedback. Authors
(DW, TW, DK) then conducted a content analysis to identify the stron
gest and most prevalent recommendations across groups.

Other recommended adaptations included omitting content on
depression and suicide. Participants were wary of how such feedback
might be (mis)used by the military. Some participating service members
discussed negative personal experiences when disclosing suicidal idea
tion within the military and described how it might lead to distrust of the
intervention. The research team decided that the clinical utility of
feedback on suicide and depression was not sufficient to overcome
participants’ concerns about potential iatrogenic effects (i.e., concern
about mandated reporting, privacy, or the military finding out about the
information and using it to prevent promotion).
A final recommendation was to normalize responses to trauma. As
one stated, “Traumatic events are all different, but we’re all dealing with
the same symptoms.” Though this was originally an aspect of the clinical
protocol, normalization became a more central theme of the interven
tion and was explicitly embedded in the review of PTSD symptoms and
etiology, and discussion of treatment options.

2.3.3. Refinement of intervention component
One key recommendation was to mitigate stigma associated with
PTSD treatment. Consistent with research on marketing Check-Up in
terventions with military populations [24], confidentiality is para
mount. In addition to clearly stating confidentiality in ad copy,
participants suggested including “Command NOT involved” to reassure
viewers that the intervention is provided outside the military system.
Another recommendation was to differentiate marketing materials from
the military through design (e.g., deviate from military aesthetics,
include university logo). As one member of the non-treated group stated,
the ads looked “super civilian” – a positive attribute signaling that the
military is not involved in the research.
Consistent with our draft marketing materials, participants also
recommended that advertisements not directly name “PTSD” due to
associated stigma. Additionally, many service members with PTSD are
unaware of their diagnosis and may not relate to the label. Instead, ads
address easily identifiable and less-stigmatized PTSD symptoms, such as
nightmares, loss of interest in activities, or feeling isolated. Some
symptoms of hyperarousal were recommended to include (irritability,
difficulty concentrating, trouble sleeping) whereas hypervigilance and
startle were not recommended as they were seen as part of situational
awareness central to military training.
Treatment providers cautioned that avoiding painful memories is
typically believed to be a useful coping strategy and therefore not a
symptom to induce treatment seeking. However, avoidance of oncepleasurable activities (e.g., sporting events, restaurants) was suggested
to be a relatable experience that the target population would be eager to
overcome. With regard to mood-related symptoms, members of the
treatment provider group expressed concern that images portraying
service members in emotional distress or isolation may be off-putting or
even “triggering”. However, the two groups of service members
expressed no such concern and found these images drew their interest.
Sample final recruitment materials can be seen in Fig. 1.
Focus group participants emphasized the importance of variety with
respect to ad placement. They explained that individual service mem
bers’ on-post movement is fairly routine and largely dictated by job
roles, so there are few locations that all service members will visit. As
such, we will strive to place advertisements as widely as possible and in
diverse locations, such as gyms, recreation centers (e.g., bowling alley,
skating rink, gaming centers, etc.), movie theaters, administrative
buildings, barracks, medical facilities, as well as in monthly printed
periodicals with on-post circulation. Participants also suggested place
ment that allowed service members to read the material discretely given
the stigma associated with mental health treatment. Accordingly, we
will also print materials in a variety of sizes, for example 11- by 17-in.
posters with large print posted on walls that can be read from across a
room and stacks of small 3- by 5-in. cards that can be taken and read
later. It was also suggested to post materials in places of privacy, such as
bathroom stalls and locker rooms.
Focus groups suggested modifications to intervention structure that
depart from prior Check-Up interventions. For example, service mem
bers recommended starting the PFR with a review of life goals – a pos
itive component that typically concludes a PFR. One soldier commented
“I am tired of being told I’m broken.” When asked about motivations for
treatment, a soldier who had completed PTSD treatment highlighted the
goal orientation of her and her peers, stating “The reason we’re in the
military is because we want a career.” Another followed up, explaining
“There is a fear that PTS will affect transition into the civilian world;
soldiers want to be productive after the military, and PTS treatment will
help with that.” Starting the PFR with goals roots the conversation in a
strengths-based perspective and engages the participant in exploring
PTSD symptoms within the context of their life and vision for the future.

2.4. Phase 2: randomized controlled trial
2.4.1. Design
The efficacy of StressCheck will be compared to treatment-as-usual
(TAU) in a two-arm randomized trial. Participants (N = 200),
recruited from JBLM via marketing materials developed in Phase 1, will
be randomly assigned to receive MET or TAU. Both interventions will be
preceded by a baseline assessment with follow-ups conducted 6-weeks,
3-, and 6-months post-baseline. Participants will complete all study ac
tivities by phone and will be compensated up to $200 for completing
assessments – $25 for baseline and 6-weeks, $50 for 3- and 6-months,
and a $50 bonus for completing all follow-ups. Hypotheses are: (1)
Service members receiving MET will report more PTSD treatment
engagement at follow-up relative to TAU. (2) Service members receiving
MET will experience fewer PTSD symptoms at follow-up relative to TAU.
(3) Intervention effects on PTSD symptoms will be mediated by PTSD
treatment engagement. (4) Intervention effects on PTSD treatment
engagement will be mediated by decreased perceived stigma and
increased perceived effectiveness of PTSD treatment.
2.4.2. Assessment, enrollment and randomization
A small team of study assessors will be responsible for conducting
screenings, enrolling participants, and conducting all follow-up in
terviews. Qualification for assessor positions will require a master’s
degree in a clinical discipline, such as psychology, social work, or
marriage and family therapy, and applicants familiar with military
populations will be preferred. Assessors will receive didactic training on
military culture, PTSD, as well as suicide assessment and intervention.
Assessors will practice administering assessments with other staff
members serving as mock participants prior to engaging with service
members. The study’s project director will conduct randomization
procedures, leaving assessors blind to treatment condition. When
possible, participants will be matched with the assessor who conducted
their baseline for subsequent follow-ups.
Inclusion criteria are current DSM-5 PTSD diagnosis and current
active-duty status in the U.S. Army or Air Force. Exclusion criteria
include current evidence-based treatment for PTSD, psychosis, pending
deployment that would preclude completion of follow-ups, or nonfluency in English.
After obtaining informed consent for screening, prospective partici
pants will complete a 15-min call to assess demographics, treatment
history, and probable PTSD using the Primary Care PTSD Screen for
DSM-5 (PC-PTSD) [26]. Soldiers and airmen with probable PTSD and no
current PTSD treatment engagement will be scheduled for the full
screen.
Determination of full eligibility will be made during the 90-min
telephone-delivered full-screen, based on PTSD diagnosis, using the
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) [27]. Eligible
participants will then provide informed consent, and choose confidential
3
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Fig. 1. Example recruitment print media. Note: Phone number obscured for publication.
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or anonymous enrollment. When selected, anonymity will be main
tained via pseudonyms, compensation through money orders, and con
tact via an anonymized phone number and a PO box.
Table 1 shows the purpose and administration timepoints of key
measures. Three measures will assess primary outcomes. First, a mea
sure of PTSD treatment engagement, developed for the purpose of this
trial, will assess the type (e.g., talk therapy, medication, self-help, etc.),
frequency, and focus of treatment utilized since the prior assessment
timepoint. Lifetime and past 3-month engagement to be assessed at
baseline/screening. Second, the gold standard for research-based
assessment of PTSD, the CAPS-5 [27], will be used to provide a diag
nosis and severity score for PTSD. Third, a version of the Treatment
Reactions Scale [28] adapted to assess reactions to PTSD treatment
generally (both medication and talk therapy) will be used for hypothe
sized mediators of stigma and perceptions of treatment efficacy. Other
key measures will be used to generate the PFR and provide data for
secondary outcomes. These include a two-item Readiness Ruler [29]
assessing importance of and confidence in ability to address PTSD
symptoms; the Alcohol Use Disorder Identification Test [30]; the Walter
Reed Functional Impairment Scale [31]; the Patient Health Question
naire (PHQ-9) [32] for depression; and the Daily Drinking Questionnaire
[33].
While the majority of measures will ask participants for direct selfreport of behaviors or opinions (e.g., Likert scale responses), the
CAPS-5 requires clinical knowledge and judgment. Accordingly, asses
sors will first complete an online training in CAPS-5 administration
provided by the US Department of Veterans Affairs and the National
Center for PTSD [34]. Assessors will then conduct mock sessions with
their peers as well as code audio-recorded CAPS-5 assessments con
ducted with participants. Such training will continue until reliable and
accurate scoring is achieved. Throughout the study, assessors will
continue to listen to the recording of roughly every fifth assessment
conducted and independently code the CAPS-5. Discrepancies in scoring
will be discussed as a team to maintain standards and consistency of
measurement. Finally, upon study completion, 5–10% of recorded as
sessments will be independently coded by another member of the team
and inter-rater reliability will be calculated.
A computerized restricted urn procedure will be used to stratify
randomization on four factors to ensure equivalent distribution between
conditions: gender (man/woman), PTSD severity (low/high), and ser
vice branch (Army/Air Force). High PTSD severity was defined as a cut
score of 37 as at the time of study design there were not established cutoffs for the CAPS-5.

MI skills are used throughout each session, including use of open
questions, reflective listening, affirmations, and selectively responding
to the service member’s change talk to explore and resolve ambivalence
around seeking help for PTSD.
As outlined in Table 2, Session 1 features the review of a personalized
PFR based on their baseline assessment responses. The focus is to explore
how PTSD is impacting the participant’s life, their treatment knowledge,
and perceived barriers to care. Counselors are encouraged to follow the
PFR’s general structure but focus on areas directly relevant to that
participant. The session begins by discussing participant life goals. This
segues into normative feedback about the degree of difficulty the
participant is having with each PTSD symptom cluster. Avoiding diag
nostic labels, symptoms are framed as “common responses to trauma.”
The next section covers intersections between alcohol and tobacco use
and PTSD. Then, the PFR presents feedback on the impact of PTSD on
participant functioning in physical, social, occupational, and personal
domains. This is intended as a means to begin exploring ambivalence
about PTSD treatment engagement while highlighting the discrepancy
between maintaining symptoms and functional costs of not changing.
Goals are revisited to explore how addressing PTSD might affect
achievement of those goals. Next, stigma about treatment seeking and
practical barriers to seeking care are addressed. Lastly, the intervention
provides psychoeducation about treatment efficacy and options,
including evidence-based interventions, and a range of other treatments,
self-help, and self-guided approaches and a discussion of next steps. Like
other MI-based interventions, StressCheck presumes solutions rest
within the service member, and the intervention goal is to help them
identify their own solutions and strengths.
While Session 1 contains the primary clinical material, Sessions 2
and 3 are optional supports toward help-seeking. At the beginning of
Sessions 2–3, the counselor asks about treatment engagement and PTSD
symptoms since their last session. Using an MI style, the counselor elicits
discussion of treatment seeking effort, or if plans were not acted upon,
what got in the way. These sessions center on identifying and responding
to risk factors for dropping out of treatment (increased ambivalence,
avoidance, stigma, life chaos), barriers to treatment engagement, and
identification of other therapeutic resources if necessary. For partici
pants not yet engaged in treatment, these sessions are an opportunity to
elicit their thinking about the pros and cons of doing so.
The comparison condition was selected to mirror the existing mili
tary process for identifying and encouraging treatment for personnel
who screen positive for PTSD. TAU includes a written referral list of
PTSD resources including information on in-person treatments, selfhelp, web-based, and bibliotherapy options for PTSD and comorbid
disorders. Upon study completion, TAU participants are offered the MET
intervention.

2.4.3. Study interventions
The MET consists of up to 3 phone sessions conducted by a study
counselor. Session 1 is 45–90 min; Sessions 2 and 3 are each 30–60 min.
Table 1
Measures by purpose and administration timepoint.
Purpose
Elig
Eligibility & Hypotheses
Demographics
SCID – Psychosis
Treatment Utilization
Primary Care PTSD Screen
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Treatment Reactions Scale
PFR & Secondary Outcomes
Readiness Ruler
Alcohol Use Disorder Identification Test
Walter Reed Functional Impairment Scale
Patient Health Questionnaire (PHQ-9)
Daily Drinking Questionnaire

X
X
X
X
X

Administration Timepoint
H1

H2

H3

H4

PFR

Scr
X

X

X
X

X

X

X
X

X
X
X
X
X
X

BL

X
X
X
X
X
X
X
X

6wk

3mo

6mo

X

X

X

X

X
X

X
X

X
X
X
X
X

X
X
X
X
X

X

Scr = Screening; BL = Baseline; 6wk = 6-week; 3mo = 3-month; 6mo = 6-month; Elig = Eligibility; H = Hypothesis; PFR = Personalized feedback report.
H1- Treatment Engagement; H2- Decrease in PTSD Symptoms; H3- Mediation: Treatment Utilization; H4: Mediation: Stigma & Efficacy.
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Table 2
Description of StressCheck MET sessions.

Table 2 (continued )

Session

Content

Clinical Goals

1

Participant life goals (reviewed at
the beginning and then in the
middle of the session)

• Identify participant values and
goals
• Examine potential discrepancy
between current PTSD
symptoms and life goals
• Identify consequences
associated with PTSD to build
motivation to change
• Normalize trauma responses to
reduce stigma
• Identify the role of depression
and suicidality as reasons to
build change
• Safety planning

Common Reactions to Trauma
• Review of severity of PTSD
symptom clusters based on CAPS5
• Provide psychoeducation about
PTSD
• Educate about relationships
between PTSD, depression, and
suicidality
Feedback on substance use
• Information on standard drinks
• Branch and gender specific
alcohol norms
• Information on monthly quantity
and costs of tobacco
• Discuss functional relationships
between substance use and PTSD

Impact of symptoms on functional
impairment

Self-reported barriers to PTSD
treatment

PTSD treatment effectiveness
information
Description and discussion of
treatment options
Discussion about moving toward
change

2&3

• Resource Booklets including
treatment resources for PTSD,
alcohol use, or tobacco use
Assessment of PTSD symptoms
since last session

Assessment of help-seeking
behaviors since last session.

Session

Content

Clinical Goals

• Trouble shoot and strategize
barriers to treatment
engagement and completion
• For those not seeking treatment,
offer and discuss further
resources

• Strengthen motivation to
persevere in help seeking or
treatment completion

2.4.4. Counselor training and supervision
Counselor training includes didactic review of MI/MET principles
and the intervention manual, modeling of therapy techniques, and roleplay of intervention strategies. Counselors will hold a graduate degree in
psychology or social work and have clinical experience with PTSD.
Counselor training consists of 20 h over 4–6 weeks with the PIs. Coun
selors will conduct “mock” MET sessions with other project staff which
will be digitally recorded and reviewed in weekly supervision. Coun
selors will then be assigned at least one training case.
All training sessions will be coded (author DW) using an adapted
version of the Motivational Interviewing Treatment Integrity (MITI)
[35] system (see below) to measure treatment fidelity for MI. Individual
supervision sessions are held weekly for the duration of the pilot cases,
where counselors receive written and oral feedback on their perfor
mance and MITI counselor behavior counts. Group supervision will be 1
h weekly throughout the trial in which clinical case material will be
presented, digital recordings of sessions reviewed, and problems of
adherence to protocols discussed.

• Develop a discrepancy between
perceived drinking and actual
descriptive norms to create
motivation to change
• Develop a discrepancy between
personal goals and values and
substance use (alcohol or
tobacco)
• Explore specific ways substance
use may be being used to selfmedicate symptoms of PTSD
• Increase awareness of how
substance use may maintain
their PTSD symptoms or
interfere with treatment
• Provide opportunity to discuss
consequences of symptoms on
functioning
• Increase awareness of
consequences to increase
motivation to change
• Provide an opportunity to
explore what it would be like to
pursue care
• Provide an opportunity to
problem solve
• Provide an opportunity for
reinforcing change talk
• Reduce stigma around
treatment seeking
• Build self-efficacy around cur
rent and past help seeking
behaviors
• Correct misperceptions
regarding treatment efficacy
• Evoke conversation about
treatment beliefs
• Increase self-efficacy around
help-seeking
• Support autonomy
• Review and problem solve with
the counselor
• Identify next steps if any
specific action was indicated

2.4.5. Intervention fidelity
A random sample of 20% of MET sessions will be rated for adherence
and competence using the MITI [35] coding system, which has
demonstrated reliability for evaluating adherence to MI interventions
[36]. Four global scores (cultivating change talk, softening sustain talk,
partnership, and empathy) are coded on a 7-point Likert scale ranging
from “low” to “high” adherence. Behavior counts include: giving infor
mation, reflections (parsed by simple or complex), MI-adherent (exam
ples include emphasizing service member’s control, affirmations, etc.)
and MI non-adherent (examples include confronting, directing, advising
without permission). Summary scores are calculated from the behavior
counts and global scores as an index of counselor competence. Two in
dependent coders, expert in the MITI will rate tapes allowing for ana
lyses of therapeutic fidelity.
2.4.6. Analysis
The first two hypotheses address whether MET participants report
more treatment engagement and fewer PTSD symptoms at follow-up
than TAU participants. This study has 4 repeated measures from base
line to 6 months follow-up yielding up to 800 observations. Given the
nesting of observations within service members, we will run linear
mixed (a.k.a., hierarchical linear or multilevel) models [37]. Measures
of treatment engagement and PTSD symptoms will be analyzed as out
comes in separate models. Fixed effects will include indicator variables
for assessment timepoint (baseline as reference), condition (MET vs.
TAU), and the time and condition interaction. Of particular interest are
cross-level interactions between condition and time. We will consider
inclusion of additional covariates such as gender, social support, and
trauma severity to improve precision of estimates. Similar mixed effects
models will be used to test intervention effects on stigma/barriers to
treatment and treatment expectancies.
For Hypothesis 3, if effects of the interaction on the outcomes are
observed, we will test whether effects of the intervention on treatment
engagement are mediated through stigma and treatment expectancies.
Using mixed effects models, we will evaluate the effect of the inter
vention on change in treatment engagement both before and after
controlling for the putative mediators using the method described by

• Engage individual in a
conversation about their PTSD
• Evoke change talk from
discovering the consequences of
PTSD
• Focus discussion (ie. this is
what we are going to be talking
about today)
• Reinforce, maintain, and
strengthen treatment or help
seeking efforts or treatment
completion
• Build and support self-efficacy
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with PTSD who are not already in treatment will respond to a Check-Up
intervention. It is possible that the intervention will predominantly be
appealing to those who are already motivated to address their PTSD. If
so, this could lead to challenges in seeing a treatment effect as partici
pants may be primed to address their PTSD regardless of the interven
tion. In contrast, should we find that the intervention is missing the
service members who are lower in motivation to change, this would
argue for finding other ways to reach these service members, such as use
of a Check-Up following a universal screening approach like in primary
care settings where it could be implemented following a positive PTSD
screen.
One strength of this study, and challenge, was the focus on creating
an intervention that would be appealing to, and pull in, service members
who are non-treatment seeking. This led to several design considerations
including the type and messaging of the marketing campaign, the use of
mass outreach to identify potential participants, and the incorporation
of feedback from end users into development of study materials. Often
treatment developers may develop interventions or recruitment mate
rials without the voices of end-users being included in the process. It is
important to highlight that provider and service member perspectives on
outreach and on intervention content did not always align, which again
suggests that interventions that are developed solely with input from
other mental health professionals may not always appeal to the target
audience. Moreover, by including both service members who had
engaged in treatment, and those who had not, we were able to represent
a broad array of reasons to address PTSD and barriers to doing so. What
is appealing to someone who had completed treatment also could, and
did, vary from what is appealing for someone who has not yet started
that process. Overall, this approach has broader applicability for inter
vention development in appealing not just to those who deliver treat
ments and those who engage in the treatment but also those who could
benefit from care, but never come in the door. If efficacious, this work
has several implications for the military. PTSD is prevalent within ser
vice members. The Department of Defense has invested considerable
resources into training and scaling up evidence-based treatments for
PTSD but barriers still remain preventing affected service members from
engaging with those resources. There are perceptions among service
members that treatment is difficult and/or inefficacious, as well as that a
diagnosis of PTSD will hamper one’s career potential [21,40,41].
StressCheck is a potential means of addressing these issues. Moreover,
the military has relatively unique opportunities for scaling up and sus
taining a successful intervention. Behavioral health treatment is avail
able within the military and covered under insurance benefits. A CheckUp, if successful, may be particularly suited for the military because
specific practical barriers to treatment such as cost and access are
reduced for those who decide to enter treatment. In addition, with an
integrated behavioral health system, it is more feasible to incorporate a
treatment program like a Check-Up into this type of system. Imple
mentation of such a service might best be rolled out within military
service providers who offer more opportunities for privacy such as
chaplains or military and family life counselors. Military and family life
counselors provide services without maintaining records to increase
privacy and confidentiality, do not report to Command, and do not
impact the security clearance of the service member, thus may be
viewed as a trusted resource for conversations pertaining to PTSD.
Future research could also investigate whether the Check-Up could be
delivered by peers and what barriers and facilitators to engaging with
these various implementation options might present.
The study, as developed, does have several limitations. One potential
issue is that our measures of treatment engagement and subsequent
PTSD improvement could be affected by access to care issues that we
cannot control. For example, if service members are not able to get into
effective treatments, regardless of how successful our MET intervention
is, it will be difficult to show an effect. This is a potential confound that
we can mitigate through measurement of treatment seeking efforts, not
just treatment engagement per se. Another limitation is that we may

Krull and MacKinnon [38]. Reduction in the percentage of variance
accounted for by the interaction effect after controlling for these pro
posed mediators will inform the degree to which the effect is mediated.
2.4.7. Statistical power
This study is primarily powered to detect differences in PTSD
symptoms between conditions over time. We used a simulation-based
approach to estimate power [39]. Two-hundred datasets were gener
ated based on the linear mixed model described in the Analysis Plan
where estimates for model parameters (e.g., baseline levels of PTSD
symptoms, changes over time in the control condition, distributions of
random effects) were guided by preliminary data from an earlier clinical
trial and the extant literature. The model was fit for each dataset and
specific outputs such as the regression coefficient and standard error. A
number of simulation runs were conducted varying treatment effects
size and the sample size. The percentage of datasets where the
treatment-by-time interactions were statistically significant provides an
estimate of power. We found that a sample size of 200 would allow for
>0.80 power to detect effect sizes of 0.35 or greater at any given followup, which is at the lower end of the effect size range found in the extant
literature on treatment for PTSD in military samples.
3. Discussion
There is limited evidence on interventions to attract and motivate
those with untreated PTSD to engage with treatment. The present study
protocol, a randomized comparison trial of a Check-Up intervention as
compared to TAU, will help address that gap. Developing a Check-Up
model to target self-referral of those suffering with PTSD involves
both an advertisement campaign to elicit voluntary participation from
those who are experiencing PTSD, but not accessing care and to decrease
barriers to engaging in an intervention. This is in contrast to offering a
MET session to service members identified in an opportunistic setting
such as a clinic or through medical records because it has the ability to
reach those who are not being identified by other institutions or services
and could capitalize on inherent motivation of the service member to
change their circumstances or how they feel.
Addressing PTSD in a MI or MET intervention may require a different
approach than addressing health behaviors. One premise of MI is that
the main obstacle to behavior change is ambivalence about change or
lack of motivation – not a skills deficit. Thus, drawing out readiness to
change sparks behavior modifications, rather than increased education
or skill development. The focus is on changing behavior that is within
the control of the service member. Counselors increase motivation by
eliciting statements that are in favor of change. In contrast, PTSD re
covery is thought to require more than resolving ambivalence. Thus,
change talk for PTSD addresses categories such as why they want to
change their PTSD and benefits of not having PTSD. Target behaviors for
MI when addressing PTSD may include increased awareness of the costs
of PTSD and increasing awareness of the benefits of resolving or
improving PTSD, to increase motivation. However, counselors are also
targeting behaviors adjacent to PTSD such as treatment entry and
engagement. Therefore, areas of feedback include data on treatment
effectiveness and didactic information related to treatments for PTSD
that may be helpful in changing perceptions about the helpfulness of
treatment and increase awareness of treatment options. MET is a flexible
approach in terms of its relation to treatment; it can serve as a direct,
standalone treatment, a precursor to treatment and facilitate treatment
engagement, or it can occur after treatment to improve maintenance of
treatment gains. Given our current focus on improving outcomes for
non-treatment-seeking service members with PTSD, the primary aim of
the current MET is to facilitate treatment seeking, broadly defined. That
is, the intervention will be considered successful if it helps participants
move toward seeking any form of PTSD treatment that they deem to be a
good fit.
It is an open question regarding what proportion of service members
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have a truncated range of readiness to change, which could obscure
treatment effects. Thus, readiness to change will be measured, both as a
potential confound and a potential moderator of treatment effects. In
addition, participants will be compensated for research participation.
Although they are not compensated for the treatment sessions they are
for completion of assessments. This can create additional reasons to
participate in a clinical trial and could lead to recruitment of service
members with lower motivation to change. If so, this could create dif
ficulties when rolling out an intervention in a standard clinical setting,
as the financial incentives would not be sustainable. In sum, this study
focused on testing an often-used approach (MI) for increasing PTSD
treatment initiation within an at-risk population of service members
with PTSD but unlikely to seek treatment. This study will also address
whether decreasing perceived stigma and increased perceived effec
tiveness are important mediators of treatment effects, thereby identi
fying mechanisms of behavior change. If this trial of StressCheck
demonstrates evidence of efficacy, the approach has potential for broad
public health impact within the military.
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